Profil
Ms. Meghna Chowdary is a Senior VP-Commercial Strategy & Operations at Olema Pharmaceuticals, Inc. Ms. Chowdary was previously employed as a Senior Vice President-Commercial by Arrivent BioPharma, Inc. and a Vice President-Commercial Operations & Analytics by Portola Pharmaceuticals LLC.
She received her undergraduate degree from Stanford University School of Medicine and an MBA from the University of Pennsylvania.
Postes actifs de Meghna Chowdary
| Sociétés | Poste | Début |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Directeur des opérations | 30/12/2025 |
Anciens postes connus de Meghna Chowdary
| Sociétés | Poste | Fin |
|---|---|---|
| ARRIVENT BIOPHARMA, INC. | Corporate Officer/Principal | 01/12/2025 |
| PORTOLA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| OLEMA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formation de Meghna Chowdary
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Portola Pharmaceuticals LLC
Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University School of Medicine
Stanford University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Arrivent BioPharma, Inc.
Arrivent BioPharma, Inc. Pharmaceuticals: OtherHealth Technology Engages in development and commercialization of cancer medicines | Health Technology |
















